Invesco Ltd.

Position in TRVI — Trevi Therapeutics, Inc.

CIK 914208 Atlanta, GA

Position in TRVI

as of Mar 31, 2026 · filed May 12, 2026 Compact

Position Value

$4,211,096

-$2,035,456 QoQ

Shares Held

352,984

-29.3% QoQ

Ownership

0.249%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2023

12 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 99.19203136686082.ToString("F0")% None 0.8079686331391791.ToString("F0")%

Healthcare · as of Mar 31, 2026

Invesco Ltd. holds $8,193,805,089 across 258 Biotechnology names. TRVI ranks #87 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	1,724,478	$1,332,400,669
2	VRTX	Vertex Pharmaceuticals Inc / Ma	2,561,057	$1,143,614,384
3	ARGX	Argenx SE	594,697	$434,277,482
4	ALNY	Alnylam Pharmaceuticals, Inc.	1,291,726	$427,393,371
5	INCY	Incyte Corp	3,870,764	$364,316,298
6	BBIO	BridgeBio Pharma, Inc.	4,592,814	$341,062,362
7	INSM	INSMED Inc	1,988,968	$325,236,040
8	HALO	Halozyme Therapeutics, Inc.	4,012,494	$259,327,483

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$4,211,096	352,984	-29.3%	Shares	Defined	2026-05-12
2025-12-31	$6,246,552	498,926	+3.3%	Shares	Defined	2026-02-19
2025-09-30	$4,420,088	483,070	+49.9%	Shares	Defined	2025-11-13
2025-06-30	$1,763,193	322,339	-62.2%	Shares	Defined	2025-08-13
2025-03-31	$5,365,275	852,985	+3511.1%	Shares	Defined	2025-05-12
2024-12-31	$97,316	23,621	+21.2%	Shares	Defined	2025-02-13
2024-09-30	$65,089	19,488	-1.2%	Shares	Defined	2024-11-12
2024-06-30	$58,773	19,723	-0.8%	Shares	Defined	2024-08-13
2024-03-31	$68,613	19,888	0.0%	Shares	Defined	2024-05-14
2023-12-31	$26,649	19,888	+23.9%	Shares	Defined	2024-02-13
2023-09-30	$34,979	16,046	0.0%	Shares	Defined	2023-11-13
2023-06-30	$38,349	16,046	—	Shares	Defined	2023-08-11
No filing history on record for this holder in this stock.